$1.60
0.0452.88%
Last update: Nov 11, 9:07 AM
PAVmed Inc
PAVMNASDAQ
PAVmed fell 85.1% from $10.50 to $1.56, behind the S&P 500's +9.8%. Its worst day was Oct 1 (−28.7%), and its low came Nov 5 at $1.55.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.60 beat the $-6.00 estimate on $5,000.00 revenue (est. $12,500.00).
−8.5% · S&P 500 −1.7%
PAVmed closed at its highest level of the year, 14.8% above where the year started.
Story events cover the past 12 months · Times ET
+94.7%, the year's best day, on 55M shares, the year's heaviest volume · S&P 500 +1.2%
EPS of $-1.05 beat the $-4.62 estimate on $52,000.00 revenue (est. $25,000.00).
+13.0% · S&P 500 −0.3%
EPS of $-1.17 missed the $-0.71 estimate on $22,000.00 revenue (est. $79,200.00).
+0.6% · S&P 500 −1.2%
EPS of $-0.27 beat the $-0.64 estimate on $33,000.00 revenue (est. $48,000.00).
+9.7% · S&P 500 −0.2%
PAVmed shares fell 28.7%, while the S&P 500 rose 0.2%.
−28.7%, the year's worst day · S&P 500 +0.2%
PAVmed closed at its lowest level of the year, 85.2% below where the year started.
−6.6% · S&P 500 −4.4%
Where it ended: a close of $1.56 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 13, 2026 (EPS est. $-0.73, revenue est. $25,000.00).
Nothing in the past 12 months.
All PAVM dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for PAVM and SPY from Benzinga historical bars. Not investment advice.
